Document is current

Article History

Received: 23 April 2024

Accepted: 29 January 2025

First Online: 21 February 2025

Declarations

:

: The animal studies were approved by the Institutional Animal Care and Use Committee, West China Hospital, Sichuan University (No.2021704 A). The title of the approved project is as follows: Study on the mechanism of mesenchymal stem cells and their secretions in alleviating the occurrence and development of liver failure (Approval date: March 2, 2021). The human MSCs isolation was approved by West China Second University Hospital of Sichuan University (No.2023013). The title of the approved project is as follows: Optimization of clinical cohorts for placental implantable diseases (Approval date: Feb 10, 2023). The animal experiments were carried out according to the Basel Declaration. The collection of human liver tissue and the use of these specimens for scientific research are approved by the Ethics Committee of West China Hospital of Sichuan University (No.2021532). The title of the approved project is as follows: Clinical observational study of disease progression and long-term prognosis in patients with fatty liver disease based on serology, imaging and pathology (Approval date: September 2, 2021). The patient’s liver tissue is derived from the liver tissue that has been preserved after the necessary medical treatment or diagnostic procedures and has previously signed written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: We declare that we have not use AI-generated work in this manuscript.